Cytokines and the inception of CD8 T cell responses

Trends in Immunology

Volumn 32, Issue 4, 2011, Pages 180-186

  Cox, Maureen A ^a   Harrington, Laurie E ^b   Zajac, Allan J ^a  

^a University of Alabama at Birmingham   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 2; INTERLEUKIN 21;

CD8+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELL POPULATION; CELL SURVIVAL; HUMAN; IMMUNE RESPONSE; INFLAMMATION; MEMORY T LYMPHOCYTE; NONHUMAN; PROTEIN FUNCTION; REVIEW;

ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; IMMUNITY, INNATE; IMMUNOLOGIC MEMORY; INFLAMMATION; INTERLEUKIN-2; INTERLEUKINS;

EID: 79953068965     PISSN: 14714906     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.it.2011.01.004     Document Type: Review

References (71)

1. + T cell differentiation. J. Exp. Med. 2010, 207:1235-1246.
2. Schepers K., et al. Dissecting T cell lineage relationships by cellular barcoding. J. Exp. Med. 2008, 205:2309-2318.
3. + T cell precursor can develop into diverse effector and memory subsets. Immunity 2007, 27:985-997.
4. Joshi N.S., Kaech S.M. Effector CD8 T cell development: a balancing act between memory cell potential and terminal differentiation. J. Immunol. 2008, 180:1309-1315.
5. Cox M.A., Zajac A.J. Shaping successful and unsuccessful CD8 T cell responses following infection. J. Biomed. Biotechnol. 2010, 2010:159152.
6. + T cells and their conversion to memory T cells. Immunol. Rev. 2010, 236:151-166.
7. O'Shea, J.J. and Paul, W.E. (2010) Mechanisms underlying lineage commitment and plasticity of helper CD4+ T cells. Science 327, 1098-1102.
8. Croft M., et al. Generation of polarized antigen-specific CD8 effector populations: reciprocal action of interleukin (IL)-4 and IL-12 in promoting type 2 versus type 1 cytokine profiles. J. Exp. Med. 1994, 180:1715-1728.
9. + T cells secreting Th1 or Th2 cytokines. Immunity 1995, 2:271-279.
10. + T cells. J. Immunol. 2009, 182:5296-5305.
11. + Tc17 cells with reduced cytotoxic activity. Eur. J. Immunol. 2009, 39:1716-1725.
12. Yen H.R., et al. Tc17 CD8 T cells: functional plasticity and subset diversity. J. Immunol. 2009, 183:7161-7168.
13. Curtsinger J.M., Mescher M.F. Inflammatory cytokines as a third signal for T cell activation. Curr. Opin. Immunol. 2010, 22:333-340.
14. + T cells. J. Immunol. 1999, 162:3256-3262.
15. Curtsinger J.M., et al. Type I IFNs provide a third signal to CD8 T cells to stimulate clonal expansion and differentiation. J. Immunol. 2005, 174:4465-4469.
16. + T cells in vivo. J. Immunol. 1999, 163:2561-2567.
17. Cui W., et al. Effects of Signal 3 during CD8 T cell priming: Bystander production of IL-12 enhances effector T cell expansion but promotes terminal differentiation. Vaccine 2009, 27:2177-2187.
18. Pearce E.L., Shen H. Generation of CD8 T cell memory is regulated by IL-12. J. Immunol. 2007, 179:2074-2081.
19. Schmidt C.S., Mescher M.F. Peptide antigen priming of naive, but not memory, CD8 T cells requires a third signal that can be provided by IL-12. J. Immunol. 2002, 168:5521-5529.
20. Valenzuela J., et al. The roles of IL-12 in providing a third signal for clonal expansion of naive CD8 T cells. J. Immunol. 2002, 169:6842-6849.
21. + T cell fates via the graded expression of T-bet transcription factor. Immunity 2007, 27:281-295.
22. + T cell contraction is controlled by early inflammation. Nat. Immunol. 2004, 5:809-817.
23. + T cell fate by regulating the expression of transcription factors T-bet and Eomesodermin. Immunity 2010, 32:67-78.
24. + T cell fate coupled by T-bet and eomesodermin. Nat. Immunol. 2005, 6:1236-1244.
25. + T cells to compete for the memory cell niche. J. Immunol. 2010, 185:4988-4992.
26. Araki K., et al. mTOR regulates memory CD8 T-cell differentiation. Nature 2009, 460:108-112.
27. Pearce E.L., et al. Enhancing CD8 T-cell memory by modulating fatty acid metabolism. Nature 2009, 460:103-107.
28. Gazzinelli R.T., et al. Parasite-induced IL-12 stimulates early IFN-gamma synthesis and resistance during acute infection with Toxoplasma gondii. J. Immunol. 1994, 153:2533-2543.
29. Konecny P., et al. Murine dendritic cells internalize Leishmania major promastigotes, produce IL-12 p40 and stimulate primary T cell proliferation in vitro. Eur. J. Immunol. 1999, 29:1803-1811.
30. d'Ostiani C.F., et al. Dendritic cells discriminate between yeasts and hyphae of the fungus Candida albicans. Implications for initiation of T helper cell immunity in vitro and in vivo. J. Exp. Med. 2000, 191:1661-1674.
31. Baum A., Garcia-Sastre A. Induction of type I interferon by RNA viruses: cellular receptors and their substrates. Amino Acids 2010, 38:1283-1299.
32. Mossman K.L., Ashkar A.A. Herpesviruses and the innate immune response. Viral Immunol. 2005, 18:267-281.
33. Thompson L.J., et al. Innate inflammatory signals induced by various pathogens differentially dictate the IFN-I dependence of CD8 T cells for clonal expansion and memory formation. J. Immunol. 2006, 177:1746-1754.
34. Muller U., et al. Functional role of type I and type II interferons in antiviral defense. Science 1994, 264:1918-1921.
35. Kolumam G.A., et al. Type I interferons act directly on CD8 T cells to allow clonal expansion and memory formation in response to viral infection. J. Exp. Med. 2005, 202:637-650.
36. Agarwal P., et al. Gene regulation and chromatin remodeling by IL-12 and type I IFN in programming for CD8 T cell effector function and memory. J. Immunol. 2009, 183:1695-1704.
37. Marshall H.D., et al. IFN-αβ and self-MHC divert CD8 T cells into a distinct ifferentiation pathway characterized by rapid acqisition of effector functions. J. Immunol. 2010, 185:1419-1428.
38. c family cytokines. Nat. Rev. Immunol. 2009, 9:480-490.
39. + T cell memory despite formation of potent T cell effectors. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:9311-9316.
40. Tripathi P., et al. STAT5 is critical to maintain effector CD8+ T cell responses. J. Immunol. 2010, 185:2116-2124.
41. Hand T.W., et al. Differential effects of STAT5 and PI3K/AKT signaling on effector and memory CD8 T-cell survival. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:16601-16606.
42. + T cells become nonresponsive (anergic) following activation in the presence of costimulation. J. Immunol. 1999, 163:102-110.
43. Tham E.L., et al. Activation-induced nonresponsiveness: a Th-dependent regulatory checkpoint in the CTL response. J. Immunol. 2002, 168:1190-1197.
44. Williams M.A., et al. Interleukin-2 signals during priming are required for secondary expansion of CD8+ memory T cells. Nature 2006, 441:890-893.
45. + T cell responses in acute and chronic viral infections. Eur. J. Immunol. 2007, 37:1502-1512.
46. + T cells in primary and secondary responses. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:193-198.
47. Pipkin M.E., et al. Interleukin-2 and inflammation induce distinct transcriptional programs that promote the differentiation of effector cytolytic T cells. Immunity 2010, 32:79-90.
48. + T cells favors terminal-effector differentiation in vivo. Immunity 2010, 32:91-103.
49. + T cell priming regulate the generation of central memory cells. J. Immunol. 2010, 185:263-272.
50. Gong D., Malek T.R. Cytokine-dependent Blimp-1 expression in activated T cells inhibits IL-2 production. J. Immunol. 2007, 178:242-252.
51. Crotty S., et al. Effectors and memories: Bcl-6 and Blimp-1 in T and B lymphocyte differentiation. Nat. Immunol. 2010, 11:114-120.
52. + T cell differentiation. J. Immunol. 2006, 177:7515-7519.
53. + memory T cell accumulation. Eur. J. Immunol. 2007, 37:3069-3077.
54. Elsaesser H., et al. IL-21 is required to control chronic viral infection. Science 2009, 324:1569-1572.
55. Frohlich A., et al. IL-21R on T cells is critical for sustained functionality and control of chronic viral infection. Science 2009, 324:1576-1580.
56. Yi J.S., et al. A vital role for interleukin-21 in the control of a chronic viral infection. Science 2009, 324:1572-1576.
57. Shin H., Wherry E.J. CD8 T cell dysfunction during chronic viral infection. Curr. Opin. Immunol. 2007, 19:408-415.
58. Yi J.S., et al. T-cell exhaustion: characteristics, causes and conversion. Immunology 2010, 129:474-481.
59. + T cell expansion and is not required for tumor immunity. J. Immunol. 2009, 183:7326-7336.
60. Yi J.S., et al. IL-21 deficiency influences CD8 T cell quality and recall responses following an acute viral infection. J. Immunol. 2010, 185:4835-4845.
61. Kaka A.S., et al. Genetic modification of T cells with IL-21 enhances antigen presentation and generation of central memory tumor-specific cytotoxic T-lymphocytes. J. Immunother. 2009, 32:726-736.
62. + T-cell responses. Eur. J. Immunol. 2010, 40:3085-3096.
63. + T cells for adoptive immunotherapy. Blood 2008, 111:5326-5333.
64. Jeannet G., et al. Essential role of the Wnt pathway effector Tcf-1 for the establishment of functional CD8 T cell memory. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:9777-9782.
65. + T cells depend on T cell factor 1. Immunity 2010, 33:229-240.
66. Kwon H., et al. Analysis of interleukin-21-induced Prdm1 gene regulation reveals functional cooperation of STAT3 and IRF4 transcription factors. Immunity 2009, 31:941-952.
67. Mouawad R., et al. Treatment for metastatic malignant melanoma: old drugs and new strategies. Crit. Rev. Oncol. Hematol. 2010, 74:27-39.
68. Gougeon M.L., Chiodi F. Impact of gamma-chain cytokines on T cell homeostasis in HIV-1 infection: therapeutic implications. J. Intern. Med. 2010, 267:502-514.
69. Blattman J.N., et al. Therapeutic use of IL-2 to enhance antiviral T-cell responses in vivo. Nat. Med. 2003, 9:540-547.
70. Sondergaard H., Skak K. IL-21: roles in immunopathology and cancer therapy. Tissue Antigens 2009, 74:467-479.
71. Chang J.T., et al. Asymmetric T lymphocyte division in the initiation of adaptive immune responses. Science 2007, 315:1687-1691.